Search by Drug Name or NDC

    NDC 11822-0019-03 Lansoprazole 15 mg/1 Details

    Lansoprazole 15 mg/1

    Lansoprazole is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Rite Aid Corporation. The primary component is LANSOPRAZOLE.

    Product Information

    NDC 11822-0019
    Product ID 11822-0019_9daacc79-4b07-1816-f25d-163fd7de4b9c
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Lansoprazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lansoprazole
    Product Type HUMAN OTC DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 15
    Active Ingredient Units mg/1
    Substance Name LANSOPRAZOLE
    Labeler Name Rite Aid Corporation
    Pharmaceutical Class Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202194
    Listing Certified Through 2024-12-31

    Package

    NDC 11822-0019-03 (11822001903)

    NDC Package Code 11822-0019-3
    Billing NDC 11822001903
    Package 3 BOTTLE in 1 CARTON (11822-0019-3) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
    Marketing Start Date 2022-10-01
    NDC Exclude Flag N
    Pricing Information N/A